Timing and Magnitude of Initial Change in Disease Activity Score 28 Predicts the Likelihood of Achieving Low Disease Activity at 1 Year in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol: A Post-hoc Analysis of the RAPID 1 Trial

Author(s):
Heijde, D. van der; Keystone, E.C.; Curtis, J.R.; Landewe, R.B.; Schiff, M.H.; Khanna, D.; Kvien, T.K.; Ionescu, L.; Gervitz, L.M.; Davies, O.R.; Luijtens, K.; Furst, D.E.
Published
2012
Publication type
Article / Letter to editor
CERTOLIZUMAB PEGOLRHEUMATOID ARTHRITISDISEASE ACTIVITY PREDICTION
Date issued
2012-07-31
Language
English
Is part of
hdl
1887/107452
doi
10.3899/jrheum.111171